Gene therapy of malignant gliomas: A phase I study of IL-4-HSV-TK gene- modified autologous tumor to elicit an immune response

Hideho Okada; Ian F. Pollack; Michael T. Lotze; L. Dade Lunsford; Douglas Kondziolka; Frank Lieberman; David Schiff; Jason Attanucci; Howard Edington; William Chambers; Paul Robbins; Joe Baar; Donna Kinzler; Theresa Whiteside; Elaine Elder

doi:10.1089/10430340050015824

Gene therapy of malignant gliomas: A phase I study of IL-4-HSV-TK gene- modified autologous tumor to elicit an immune response

Hideho Okada, Ian F. Pollack, Michael T. Lotze, L. Dade Lunsford, Douglas Kondziolka, Frank Lieberman, David Schiff, Jason Attanucci, Howard Edington, William Chambers, Paul Robbins, Joe Baar, Donna Kinzler, Theresa Whiteside, Elaine Elder

Research output: Contribution to journal › Comment/debate › peer-review

58 Scopus citations

Original language	English (US)
Pages (from-to)	637-653
Number of pages	17
Journal	Human gene therapy
Volume	11
Issue number	4
DOIs	https://doi.org/10.1089/10430340050015824
State	Published - 2000
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1089/10430340050015824

OpenUrl availability

Full text

Cite this

Okada, H., Pollack, I. F., Lotze, M. T., Dade Lunsford, L., Kondziolka, D., Lieberman, F., Schiff, D., Attanucci, J., Edington, H., Chambers, W., Robbins, P., Baar, J., Kinzler, D., Whiteside, T., & Elder, E. (2000). Gene therapy of malignant gliomas: A phase I study of IL-4-HSV-TK gene- modified autologous tumor to elicit an immune response. Human gene therapy, 11(4), 637-653. https://doi.org/10.1089/10430340050015824

Okada, H, Pollack, IF, Lotze, MT, Dade Lunsford, L, Kondziolka, D, Lieberman, F, Schiff, D, Attanucci, J, Edington, H, Chambers, W, Robbins, P, Baar, J, Kinzler, D, Whiteside, T & Elder, E 2000, 'Gene therapy of malignant gliomas: A phase I study of IL-4-HSV-TK gene- modified autologous tumor to elicit an immune response', Human gene therapy, vol. 11, no. 4, pp. 637-653. https://doi.org/10.1089/10430340050015824

@article{a0bb60d6bc76493b8ed426e35720e274,

title = "Gene therapy of malignant gliomas: A phase I study of IL-4-HSV-TK gene- modified autologous tumor to elicit an immune response",

author = "Hideho Okada and Pollack, {Ian F.} and Lotze, {Michael T.} and {Dade Lunsford}, L. and Douglas Kondziolka and Frank Lieberman and David Schiff and Jason Attanucci and Howard Edington and William Chambers and Paul Robbins and Joe Baar and Donna Kinzler and Theresa Whiteside and Elaine Elder",

year = "2000",

doi = "10.1089/10430340050015824",

language = "English (US)",

volume = "11",

pages = "637--653",

journal = "Human gene therapy",

issn = "1043-0342",

publisher = "Mary Ann Liebert Inc.",

number = "4",

}

TY - JOUR

T1 - Gene therapy of malignant gliomas

T2 - A phase I study of IL-4-HSV-TK gene- modified autologous tumor to elicit an immune response

AU - Okada, Hideho

AU - Pollack, Ian F.

AU - Lotze, Michael T.

AU - Dade Lunsford, L.

AU - Kondziolka, Douglas

AU - Lieberman, Frank

AU - Schiff, David

AU - Attanucci, Jason

AU - Edington, Howard

AU - Chambers, William

AU - Robbins, Paul

AU - Baar, Joe

AU - Kinzler, Donna

AU - Whiteside, Theresa

AU - Elder, Elaine

PY - 2000

Y1 - 2000

UR - http://www.scopus.com/inward/record.url?scp=0034054582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034054582&partnerID=8YFLogxK

U2 - 10.1089/10430340050015824

DO - 10.1089/10430340050015824

M3 - Comment/debate

C2 - 10724042

AN - SCOPUS:0034054582

SN - 1043-0342

VL - 11

SP - 637

EP - 653

JO - Human gene therapy

JF - Human gene therapy

IS - 4

ER -

Gene therapy of malignant gliomas: A phase I study of IL-4-HSV-TK gene- modified autologous tumor to elicit an immune response

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this